Utah Medical Products (UTMD) Enterprise Value (2010 - 2026)

Utah Medical Products' Enterprise Value history runs 17 years deep, the most recent figure standing at -$87.4 million for Q1 2026.

• On a quarterly basis, Enterprise Value fell 4.9% year-over-year to -$87.4 million in Q1 2026; TTM through Mar 2026 was -$87.4 million, a 4.9% decrease from a year earlier, with the FY2025 full-year figure at -$85.8 million, down 3.35% from the prior year.
• Enterprise Value retreated to -$87.4 million in Q1 2026 per UTMD's latest filing, from -$85.8 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$65.9 million in Q1 2022 and bottomed at -$93.8 million in Q1 2024.
• The 5-year median for Enterprise Value is -$84.3 million (2025), against an average of -$82.4 million.
• Across the five-year window, Enterprise Value slipped 27.78% in 2023 and gained 11.17% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$75.1 million in 2022, then retreated by 23.74% to -$92.9 million in 2023, then advanced by 10.65% to -$83.0 million in 2024, then decreased by 3.35% to -$85.8 million in 2025, then fell by 1.92% to -$87.4 million in 2026.
• Per Business Quant, the three latest UTMD Enterprise Value figures stand at -$87.4 million (Q1 2026), -$85.8 million (Q4 2025), and -$84.3 million (Q3 2025).